Masoud Hamidi

Dr. Masoud Hamidi

3BIO, ULB Université Libre de Bruxelles, Brussels, Brussels-Capital Region, Belgium
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2019 in Marine Drugs
Verified
Journal Article
Open access
PDF file
MHMasoud Hamidi
Masoud Hamidi
PKPooria Safarzadeh Kozani
Pooria Safarzadeh Kozani
PKPooria Safarzadeh Kozani
Pooria Safarzadeh Kozani
Guillaume PierreGuillaume Pierre
Guillaume Pierre
Philippe MichaudPhilippe Michaud
Philippe Michaud
Delattre CedricDelattre Cedric
Delattre Cedric
Natural bioactive compounds with antioxidant activity play remarkable roles in the prevention of reactive oxygen species (ROS) formation. ROS, which are formed by different pathways, have various pathological influences such as DNA damage, carcinogenesis, and cellular degeneration. Incremental demands have prompted the search for newer and alternative resources of natural bioactive compounds with antioxidant properties. The marine environment encompasses almost three-quarters of our planet and is home to many eukaryotic and prokaryotic microorganisms. Because of extreme physical and chemical conditions, the marine environment is a rich source of chemical and biological diversity, and marine microorganisms have high potential as a source of commercially interesting compounds with various pharmaceutical, nutraceutical, and cosmeceutical applications. Bacteria and microalgae are the most important producers of valuable molecules including antioxidant enzymes (such as superoxide dismutase and catalase) and antioxidant substances (such as carotenoids, exopolysaccharides, and bioactive peptides) with various valuable biological properties and applications. Here, we review the current knowledge of these bioactive compounds while highlighting their antioxidant properties, production yield, health-related benefits, and potential applications in various biological and industrial fields.

26 October 2022 in Biosensors
Verified
Journal Article
Open access
PDF file
MBMorteza Banakar
Morteza Banakar
MHMasoud Hamidi
Masoud Hamidi
Zohaib KhurshidZohaib Khurshid
Zohaib Khurshid
Muhammad Sohail ZafarMuhammad Sohail Zafar
Muhammad Sohail Zafar
JSJanak Sapkota
Janak Sapkota
Dinesh RokayaDinesh Rokaya
Dinesh Rokaya
Electrochemical biosensors are a family of biosensors that use an electrochemical transducer to perform their functions. In recent decades, many electrochemical biosensors have been created for pathogen detection. These biosensors for detecting infections have been comprehensively studied in terms of transduction elements, biorecognition components, and electrochemical methods. This review discusses the biorecognition components that may be used to identify pathogens. These include antibodies and aptamers. The integration of transducers and electrode changes in biosensor design is a major discussion topic. Pathogen detection methods can be categorized by sample preparation and secondary binding processes. Diagnostics in medicine, environmental monitoring, and biothreat detection can benefit from electrochemical biosensors to ensure food and water safety. Disposable and reusable biosensors for process monitoring, as well as multiplexed and conformal pathogen detection, are all included in this review. It is now possible to identify a wide range of diseases using biosensors that may be applied to food, bodily fluids, and even objects’ surfaces. The sensitivity of optical techniques may be superior to electrochemical approaches, but optical methods are prohibitively expensive and challenging for most end users to utilize. On the other hand, electrochemical approaches are simpler to use, but their efficacy in identifying infections is still far from satisfactory.

1 May 2020 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
MHMasoud Hamidi
Masoud Hamidi
AGAmir Reza Gholipour
Amir Reza Gholipour
Delattre CedricDelattre Cedric
Delattre Cedric
FSFaezeh Sesdighi
Faezeh Sesdighi
RSRasool Mirzaei Seveiri
Rasool Mirzaei Seveiri
FKFatemeh Karimitabar
Fatemeh Karimitabar

24 August 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
MAMohammad Foad Abazari
Mohammad Foad Abazari
SGSHAYAN GHOLIZADEH
SHAYAN GHOLIZADEH
SKShohreh Zare Karizi
Shohreh Zare Karizi
NBNazanin Hajati Birgani
Nazanin Hajati Birgani
DADanya Abazari
Danya Abazari
Delattre CedricDelattre Cedric
Delattre Cedric
Application of wound-healing/dressing biomaterials is amongst the most promising approaches for wound repair through protection from pathogen invasion/contamination, maintaining moisture, absorbing exudates, modulating inflammation, and facilitating the healing process. A wide range of materials are used to fabricate wound-healing/dressing biomaterials. Active wound-healing/dressings are next-generation alternatives for passive biomaterials, which provide a physical barrier and induce different biological activities, such as antibacterial, antioxidant, and proliferative effects. Cellulose-based biomaterials are particularly promising due to their tunable physical, chemical, mechanical, and biological properties, accessibility, low cost, and biocompatibility. A thorough description and analysis of wound-healing/dressing structures fabricated from cellulose-based biomaterials is discussed in this review. We emphasize and highlight the fabrication methods, applied bioactive molecules, and discuss the obtained results from in vitro and in vivo models of cellulose-based wound-healing biomaterials. This review paper revealed that cellulose-based biomaterials have promising potential as the wound-dressing/healing materials and can be integrated with various bioactive agents. Overall, cellulose-based biomaterials are shown to be effective and sophisticated structures for delivery applications, safe and multi-customizable dressings, or grafts for wound-healing applications.

18 May 2023 in Materials Today Bio
Verified
Journal Article
Open access
MAMehdi Azizi
Mehdi Azizi
RJRana Jahanban-Esfahlan
Rana Jahanban-Esfahlan
HSHadi Samadian
Hadi Samadian
MHMasoud Hamidi
Masoud Hamidi
KSKhaled Seidi
Khaled Seidi
Mohammad-Ali ShahbaziMohammad-Ali Shahbazi
Mohammad-Ali Shahbazi
Over the past three decades, nanoscience has offered a unique solution for reducing the systemic toxicity of chemotherapy drugs and for increasing drug therapeutic efficiency. However, the poor accumulation and pharmacokinetics of nanoparticles are some of the key reasons for their slow translation into the clinic. The is intimately linked to the non-biological nature of nanoparticles and the aberrant features of solid cancer, which together significantly compromise nanoparticle delivery. New findings on the unique properties of tumors and their interactions with nanoparticles and the human body suggest that, contrary to what was long-believed, tumor features may be more mirage than miracle, as the enhanced permeability and retention based efficacy is estimated to be as low as 1%. In this review, we highlight the current barriers and available solutions to pave the way for approved nanoformulations. Furthermore, we aim to discuss the main solutions to solve inefficient drug delivery with the use of nanobioengineering of nanocarriers and the tumor environment. Finally, we will discuss the suggested strategies to overcome two or more biological barriers with one nanocarrier. The variety of design formats, applications and implications of each of these methods will also be evaluated.

1 March 2014
Verified
Journal Article
Closed access
DNDavood Naziri
Davood Naziri
MHMasoud Hamidi
Masoud Hamidi
SHSalar Hassanzadeh
Salar Hassanzadeh
VTVahideh Tarhriz
Vahideh Tarhriz
BZBahram Maleki Zanjani
Bahram Maleki Zanjani
MHMohammad Saeid Hejazi
Mohammad Saeid Hejazi